Agreeing with our hypothesis, this tumor had a somatic mutation burden of ~8 mut/Mb, which is 10 times lower than in the three POLD1-associated hypermutable tumors described above, and comparable to the mutation rate observed in normal tissues of heterozygous carriers of POLD1 exonuclease pathogenic variants. Here, POLD1 is linked to neoplasm.